Evidence map›Paper›PMID 38201654›Full record

ArticleCancers2024

Mucosal Melanoma Clinical Management and Prognostic Implications: A Retrospective Cohort Study.

Laia Clavero-Rovira, Álvaro Gómez-Tomás, Patricia Bassas-Freixas, Domingo Bodet, Berta Ferrer, Javier Hernández-Losa, Eva Muñoz-Couselo, Assumpció Pérez-Benavente, Vicente García-Patos, Carla Ferrándiz-Pulido

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Mucosal Melanoma of Head and Neck: A Rare and Aggressive Disease-A Register-Based Cohort Study.Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology · 2026
    Article
  3. Observational
  4. Article
  5. Article
  6. Mucosal Melanoma: An Overview of Recent Therapies.Current pharmaceutical design · 2026
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Laia Clavero-RoviraDepartment of Dermatology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.ORCID 0009-0004-9957-7121
Álvaro Gómez-TomásDepartment of Dermatology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.ORCID 0000-0002-9388-5623
Patricia Bassas-FreixasDepartment of Dermatology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.
Domingo BodetDepartment of Dermatology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.ORCID 0000-0003-2227-0696
Berta FerrerDepartment of Pathology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.
Javier Hernández-LosaDepartment of Pathology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.
Eva Muñoz-CouseloDepartment of Oncology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.ORCID 0000-0001-7556-7608
Assumpció Pérez-BenaventeFacultad de Medicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Vicente García-PatosDepartment of Dermatology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.
Carla Ferrándiz-PulidoDepartment of Dermatology, University Hospital Vall d'Hebron, 08035 Barcelona, Spain.ORCID 0000-0003-3688-9596
Universitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosal melanoma (MM) is an uncommon melanoma subtype affecting mucosal surfaces of the head and neck, anorectal region, and vulvovaginal area. We aimed to present our experience at a tertiary-level hospital regarding MM diagnosis, management, monitoring of progression, mutations, and outcome predictors. We performed a registry-based cohort study including MM cases diagnosed from 2012 to 2022 and retrospectively characterized somatic mutations on

Indexed as

Breslow depthimmunotherapymucosal melanomaprognostic factorssomatic mutationssurvival outcomes

Identifiers

PMID38201654
PMCPMC10778057
OpenAlexW4390544955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.